What about Shanghai Maoradial Medicine Technology Co., Ltd.?

The data of nailed enterprise code comes from enterprise credit reporting institutions, including enterprise risk data, company official website, company profile, and more company recruitment information. For details, please refer to company official website. For more company telephone addresses and email addresses, you can inquire about nailed enterprise code.

Company profile:

Shanghai Maoradial Pharmaceutical Technology Co., Ltd. was established on 20 18-04- 17 with a registered capital of 3.75 million yuan. The legal representative is Xiao Yingxian, and the company address is Room 33 12, Room 3, Building 3, No.797 Puxing Highway, Minhang District, Shanghai. The unified social credit code and tax number are 91310/2ma1gbyepxy, and the industry serves other technology promotion. The registration authority is Shanghai Municipal Market Supervision Administration, and its business scope is engaged in technology development, technical consultation and technology in the field of medical science and technology (except the development and application of human stem cells and gene diagnosis and treatment technology). Engaged in the sales of medical devices, the import and export of goods and technologies, the research and development and sales of polymer materials, the provision of related supporting services, and the maintenance of medical devices (not involving state-owned trade management commodities, but involving commodities under quota and license management, the application shall be handled in accordance with relevant state regulations). Projects that are subject to approval according to law can only carry out business activities after being approved by relevant departments. The industrial and commercial registration number of Shanghai Maorao Pharmaceutical Technology Co., Ltd. is 3101200182612.

Shareholders:

The contribution ratio of Shanghai Zefu Investment Center (Limited Partnership) is 33.33%, and the subscribed contribution is 1 250,000,000 yuan.

Shanghai Chenbu Enterprise Management Partnership (Limited Partnership) contributed 20.00%, and the subscribed capital contribution was 750 million yuan.

Shanghai Real Radiation Enterprise Management Partnership (Limited Partnership) contributes 65,438+03.33%, and the subscribed capital is 500,000,000.

Shanghai Wante Pharmaceutical Technology (Group) Co., Ltd., with the contribution ratio of 13.33%, subscribed capital contribution of 500 million yuan.

Shanghai Pharmaceutical Blood Science and Technology Industry Development Co., Ltd. contributed 6.67%, with a subscribed capital of 250 million yuan.

Ying Chao, Jr., contributed 6.67% of the capital, and the subscribed capital contribution was RMB 250 million.

Shanghai Yuxi Equity Investment Management Co., Ltd. has a capital contribution ratio of 6.67% and subscribed capital contribution of 250 million yuan.

Executives:

Wan Wuzhou is in charge of the company.

Chen Zhong is the director and general manager of our company.

Xiao Yingxian is the chairman of this company.

Liu nai is a director of the company.

Chen Sigen is a director of the company.